Connect Investigative Site 129 — Warwick, Rhode Island

Connect Investigative Site 129 is a clinical research site located in Warwick, Rhode Island, United States 02886.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Connect Investigative Site 129 has participated in 1 clinical trials.

Therapeutic areas: Moderate to Severe Persistent Asthma.

Sponsors: Connect Biopharm LLC.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Connect Investigative Site 129?

Connect Investigative Site 129 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Connect Investigative Site 129 conducted?

Connect Investigative Site 129 has 1 clinical trials on record. Their work covers Moderate to Severe Persistent Asthma.

Is Connect Investigative Site 129 accredited by Crixeo Health?

Connect Investigative Site 129 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Connect Investigative Site 129?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.